Partnership for Part D Access
  • Home
  • The Issue
    • Six Protected Classes
    • History
    • Patient Communities
  • The People
    • From the Community
    • Clinician Advisory Board
  • The Resources
    • Video Library
  • The Newsroom
  • About Us
    • Who We Are
    • Our Leadership
    • Contact Us
  • Home
  • The Issue
    • Six Protected Classes
    • History
    • Patient Communities
  • The People
    • From the Community
    • Clinician Advisory Board
  • The Resources
    • Video Library
  • The Newsroom
  • About Us
    • Who We Are
    • Our Leadership
    • Contact Us

Resources

Congress Strengthens Six Protected Classes in MIPPA

1/3/2008

 
Picture
In 2008, under Section 176 of the Medicare Improvements for Patients and Providers Act (MIPPA), Congress strengthened the so-called protected classes policy by codifying it in the Part D statute. In a strong congressional affirmation of the ongoing importance of these protections, MIPPA required Medicare Part D drug plans to include in their formularies access to all or substantially all drugs in the six identified categories of priority. MIPPA also specified two statutory criteria that CMS had to use in identifying additional classes of clinical concern: (1) restricted access to the drugs in the class would have major or life-threatening clinical consequences for individuals with a disease or disorder treated by drugs in such class; and (2) there is a significant need for such individuals to have access to multiple drugs within a class due to unique chemical actions and pharmacological effects of the drugs within a class. Click ‘Read More’ to view the law.

Bill 1110 Congress H.R. 6331.pdf
File Size: 391 kb
File Type: pdf
Download File

The Medicare Prescription Drug, Improvement, and Modernization Act (MMA)

12/8/2003

 
Picture
​On December 8, 2003, the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) was signed into law by former President George W. Bush. Prior to the enactment of the MMA, Medicare prescription drug coverage was very limited, and was generally only available for physician-administered drugs, drugs necessary for the effective use of durable medical equipment such as inhalers, and a handful of drugs listed specifically in the statute. When Congress established the Medicare Part D prescription drug benefit, it recognized that certain drug classes were vital to the beneficiaries whose lives, in many cases, depended on those drugs, and that their prescribers needed access to the full range of treatment options. For example, Congress expressed significant concern regarding the needs of Medicare beneficiaries with mental illness, as illustrated in the Conference Report that accompanied the MMA. The MMA corrected a major gap in Medicare coverage, adding a new Part D to the program and provided coverage for FDA-approved drugs that had not previously been covered. Click "PLAW 108 Published 173' to view the law.

PLAW 108 Published 173.pdf
File Size: 1218 kb
File Type: pdf
Download File

Forward>>

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    March 2021
    February 2021
    November 2020
    January 2020
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    November 2018
    July 2018
    June 2018
    March 2018
    January 2018
    September 2017
    August 2016
    June 2016
    March 2016
    September 2014
    March 2014
    February 2014
    January 2014
    July 2011
    September 2010
    March 2010
    July 2008
    January 2008
    December 2003

    Categories

    All

    RSS Feed

Learn more

About Us
Patient Communities
​Issues
​Background

What's New?

​Newsroom
Resources
​

Contact

Contact Us
© COPYRIGHT 2018. ALL RIGHTS RESERVED.